GB1524405A - Ophthalmic compositions - Google Patents

Ophthalmic compositions

Info

Publication number
GB1524405A
GB1524405A GB39553/76A GB3955376A GB1524405A GB 1524405 A GB1524405 A GB 1524405A GB 39553/76 A GB39553/76 A GB 39553/76A GB 3955376 A GB3955376 A GB 3955376A GB 1524405 A GB1524405 A GB 1524405A
Authority
GB
United Kingdom
Prior art keywords
ophthalmic
ophthalmic compositions
compositions
sept
tbutylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB39553/76A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1524405A publication Critical patent/GB1524405A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1524405 Ophthalmic compositions MERCK & CO Inc 23 Sept 1976 [26 Sept 1975] 39553/76 Heading A5B Ophthalmic compositions comprise 1-tbutylamino-3-(4-morpholino-1, 2, 5-thiadiazole-3-yl oxy)-2-propanol hydrogen maleate, together with an ophthalmic carrier which is a solid, a vegetable oil or a buffered crotonic liquid. The compositions may be in the form of solutions, ointments or ophthalmic inserts in which the active ingredient is enclosed within polymeric material.
GB39553/76A 1975-09-26 1976-09-23 Ophthalmic compositions Expired GB1524405A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61711875A 1975-09-26 1975-09-26

Publications (1)

Publication Number Publication Date
GB1524405A true GB1524405A (en) 1978-09-13

Family

ID=24472326

Family Applications (1)

Application Number Title Priority Date Filing Date
GB39553/76A Expired GB1524405A (en) 1975-09-26 1976-09-23 Ophthalmic compositions

Country Status (12)

Country Link
AU (1) AU513280B2 (en)
BE (1) BE846574A (en)
CY (1) CY1023A (en)
GB (1) GB1524405A (en)
HK (1) HK67579A (en)
IE (1) IE44167B1 (en)
IL (1) IL50477A (en)
KE (1) KE2990A (en)
MY (1) MY8000138A (en)
NZ (1) NZ182022A (en)
PH (1) PH13467A (en)
ZA (1) ZA765752B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014642A2 (en) * 1979-02-02 1980-08-20 Merck & Co. Inc. Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitors and S-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol for topical application in the treatment of elevated intraocular pressure
US4402976A (en) 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
GB2225237A (en) * 1988-09-22 1990-05-30 Chatfield Pharmaceuticals Limi Ophthalmic preparations

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014642A2 (en) * 1979-02-02 1980-08-20 Merck & Co. Inc. Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitors and S-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol for topical application in the treatment of elevated intraocular pressure
EP0014642A3 (en) * 1979-02-02 1981-01-07 Merck & Co. Inc. Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitors and s-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol for topical application in the treatment of elevated intraocular pressure
US4402976A (en) 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
GB2225237A (en) * 1988-09-22 1990-05-30 Chatfield Pharmaceuticals Limi Ophthalmic preparations
EP0448856A1 (en) * 1988-09-22 1991-10-02 Chatfield Pharmaceuticals Limited Ophthalmic preparations comprising timolol maleate
GB2225237B (en) * 1988-09-22 1992-03-25 Chatfield Pharmaceuticals Limi Ophthalmic preparations

Also Published As

Publication number Publication date
PH13467A (en) 1980-05-15
NZ182022A (en) 1978-12-18
IL50477A0 (en) 1976-11-30
CY1023A (en) 1980-08-01
IE44167L (en) 1977-03-26
ZA765752B (en) 1978-05-30
IE44167B1 (en) 1981-08-26
BE846574A (en) 1977-03-24
AU1771476A (en) 1978-03-23
HK67579A (en) 1979-09-28
IL50477A (en) 1979-09-30
MY8000138A (en) 1980-12-31
KE2990A (en) 1979-09-28
AU513280B2 (en) 1980-11-27

Similar Documents

Publication Publication Date Title
EP0227450A3 (en) Substituted 5,6-dialkoxyquinazoline derivatives
USD258045S (en) Combined bottle and cup
CA2037150A1 (en) Retinoids
USD259920S (en) Bottle
IE44937L (en) 4-hydroxy-aporphine derivatives
GB1524405A (en) Ophthalmic compositions
GB1354571A (en) Amides and their use as insecticides
USD278820S (en) Page planning table with display monitor
USD277969S (en) Desk organizer with utility compartments
USD247472S (en) Bottle
ES380767A1 (en) Method of preparing morpholino cyano-acrylamides
ES465313A1 (en) Derivatives of naphthyridine
GB1429437A (en) Odour-reduced pesticidal compositions
AU566898B2 (en) Benz (5,6) isoindolo(z,1-b)isoquinoline -8,13-dione and their use as anti-cancer agents
ES472892A1 (en) Opthalmic compositions
USD258415S (en) Removable hinge retainer for vehicle sun roofs
ES486851A1 (en) Process for the production of ursodesoxycholic acid
IE42348L (en) Pyridazone herbicide in the form of an aqueous suspension
GB1164471A (en) Novel Oxetanes and use thereof
GB1526170A (en) 3-(5,6-dihydro-4h-1,3-thiazin-2-yl)-3-nitro-2-propenoic acid and its use as an insecticide
USD248719S (en) Gimballed beverage cup holder
USD245702S (en) Note pad holder for a telephone or the like
GB1504259A (en) Immunological control of fertility
USD244092S (en) Intermodal container
IE34730L (en) Indomethacin suppositories

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19960922